- Home
- CGTX vs SLGL Comparison
CGTX vs SLGL Comparison
Compare CGTX & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- SLGL
- Stock Information
- Founded
- CGTX 2007
- SLGL 1997
- Country
- CGTX United States
- SLGL Israel
- Employees
- CGTX N/A
- SLGL N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- CGTX Health Care
- SLGL Health Care
- Exchange
- CGTX Nasdaq
- SLGL Nasdaq
- Market Cap
- CGTX 17.9M
- SLGL 17.0M
- IPO Year
- CGTX 2021
- SLGL 2018
- Fundamental
- Price
- CGTX $0.43
- SLGL $0.57
- Analyst Decision
- CGTX Strong Buy
- SLGL Strong Buy
- Analyst Count
- CGTX 6
- SLGL 2
- Target Price
- CGTX $8.30
- SLGL $5.00
- AVG Volume (30 Days)
- CGTX 2.8M
- SLGL 46.6K
- Earning Date
- CGTX 05-06-2025
- SLGL 03-21-2025
- Dividend Yield
- CGTX N/A
- SLGL N/A
- EPS Growth
- CGTX N/A
- SLGL N/A
- EPS
- CGTX N/A
- SLGL N/A
- Revenue
- CGTX N/A
- SLGL $11,707,000.00
- Revenue This Year
- CGTX N/A
- SLGL $772.97
- Revenue Next Year
- CGTX N/A
- SLGL N/A
- P/E Ratio
- CGTX N/A
- SLGL N/A
- Revenue Growth
- CGTX N/A
- SLGL 869.93
- 52 Week Low
- CGTX $0.34
- SLGL $0.33
- 52 Week High
- CGTX $2.95
- SLGL $1.65
- Technical
- Relative Strength Index (RSI)
- CGTX 27.35
- SLGL 40.41
- Support Level
- CGTX $0.36
- SLGL $0.55
- Resistance Level
- CGTX $0.45
- SLGL $0.70
- Average True Range (ATR)
- CGTX 0.05
- SLGL 0.07
- MACD
- CGTX -0.01
- SLGL 0.01
- Stochastic Oscillator
- CGTX 23.66
- SLGL 24.48
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.